FEDERAL31d left

HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)

National Institutes of Health

Posted Sep 28, 2026

Deadline
Oct 30, 2026
31 days remaining
Amount
Varies
Status
Open
Geographic Scope
National

Description

The NIH Helping to End Addiction Long-term® (HEAL) Initiative is releasing this Notice of Funding Opportunity (NOFO) to support a phased mechanistic clinical research program focusing on understudied biological mechanisms that drive joint pain. The phased projects supported by this program (of up to five years total in duration) will first identify and validate multi-tissue mechanisms underlying joint pain, then test non-pharmacologic or multimodal interventions that directly target these mechanisms. The initiative responds to priorities identified in the 2023 HEAL Whole Joint Pain Workshop and supports the broader goals of the NIH HEAL Initiative and the Make America Healthy Again vision by advancing safe, non-addictive, and prevention-oriented approaches to chronic pain.

AI Summary

The HEAL Initiative is offering funding for research projects that explore the biological mechanisms behind joint pain and test non-drug interventions to address these issues. Eligible applicants include researchers conducting clinical trials that align with the goals of the NIH HEAL Initiative, particularly those focusing on safe and non-addictive pain management strategies.

Funding Details

Key Dates

Posted: Sep 28, 2026Deadline: Oct 30, 2026

Quick Facts

CFDA Number
93.213
Funder Type
Federal Agency
Grant Level
FEDERAL
Last Verified
Sep 28, 2026

Geographic Scope

national

ReferenceGL-74D975

74d97567-c812-4929-a268-4ce5db720188

Intelligence

Ready to apply?

Visit the funder's website to start your application.

HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required) | GrantLens